T. Rowe Price Innovation Leaders ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: --
資產淨值: 23.47
成立日期: 28/01/2026
 
分析
市值分佈:
83.53%
大市值
2.87%
中市值
--
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 209  
0%
 
100%
     10大 (25.87%)
代號 名稱 佔比% 持有日期
CAICaris Life Sciences Inc0.1528/02/2026
CYTKCytokinetics0.1528/02/2026
APGEApogee Therapeutics0.1428/02/2026
GLUEMonte Rosa Therapeutics0.1428/02/2026
GPNGlobal Payments0.1428/02/2026
INCYIncyte Corp0.1428/02/2026
VRSKVerisk Analytics0.1428/02/2026
BEAMBeam Therapeutics0.1328/02/2026
EADSFAirbus SE0.1328/02/2026
SYRESpyre Therapeutics0.1328/02/2026
SONVFSonova Holding AG0.1328/02/2026
IMNMImmunome0.1328/02/2026
NVONovo-Nordisk A/S0.1228/02/2026
BLTEBelite Bio0.1128/02/2026
ONCBeOne Medicines Ltd0.1128/02/2026
FNNTFFLATEXDEGIRO AG0.1128/02/2026
TEVATeva Pharmaceutical Industries Limited0.1128/02/2026
XPXP0.1128/02/2026
PAYOPayoneer Global0.1128/02/2026
ICEIntercontinental Exchange0.1128/02/2026
  1    2    3    4    5    6    7   8    9    10    11  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.